Rosenbaum Jay D. Amgen Inc Transaction History

Rosenbaum Jay D.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$233.58 - $259.14 $420,444 - $466,452	-1,800 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $177,528 - $206,880	-800 Reduced 30.77%	1,800 $448,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $819,351 - $1.09 Million	-4,496 Reduced 63.36%	2,600 $527,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $274,354 - $352,640	1,450 Added 25.68%	7,096 $1.71 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $656,394 - $786,497	-3,770 Reduced 40.04%	5,646 $1.09 Million
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $35,007 - $41,036	-210 Reduced 2.18%	9,416 $1.74 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $3,321 - $3,730	-20 Reduced 0.21%	9,626 $1.78 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $3,375 - $3,771	20 Added 0.21%	9,646 $1.68 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $1.61 Million - $1.84 Million	9,626	9,626 $1.8 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

Stay updated on Rosenbaum Jay D. with notifications on news.